Filing Details
- Accession Number:
- 0001209191-19-041911
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-12 16:04:43
- Reporting Period:
- 2019-07-10
- Accepted Time:
- 2019-07-12 16:04:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635794 | Antonio Gualberto | C/O Kura Oncology, Inc. 3033 Science Park Road, Suite 220 San Diego CA 92121 | Head Of Development & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-07-10 | 18,000 | $6.15 | 357,973 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-07-10 | 18,000 | $21.11 | 339,973 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option to purchase common stock | Disposition | 2019-07-10 | 18,000 | $0.00 | 18,000 | $6.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 151,000 | 2027-01-22 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.
- This transaction was executed in multiple trades at prices ranging from $21.10 to $21.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
- This option vests in 48 equal monthly installments commencing on the grant date.
Billionaire Hedge Funds
